Skip to content

PDEPIREUXNEURO

Active Private limited companyfounded 2018active for 8 yearsLeuvensebaan 194A, 3040 HuldenbergKBO/BCE: BE 0690.602.287 #6 oldest company in Huldenberg, Health and social work sector

Lifetime

8 annual accounts with figures on one time axis
peak of €173,347 in 2024
€110,474▼ 36.3%
peak of €124,552 in 2024
€76,062▼ 38.9%
peak of €114,335 in 2020
€21,266▲ 0.3%
€298,284▲ 22.5%
Board1 name since 2018
1 director
Documentsfilings and deeds
07-05-202685 days before the deadline
2025micro format
Gross margin from €173,347 to €110,474Result from €124,552 to €76,062Dividend €76,000Debts from €243,585 to €298,284Cash from €139,655 to €209,446

Key points

from the 2025 annual accounts

Equity

€21,266 from €114,335 in 2020

Equity fell by 81% in 5 years.

Turnover

≈ €210,000 estimated

The micro format states no turnover.

Debts

€298,284 93% of the balance sheet

Filings

8 annual accounts 2 late
AprilJune31 JulyOctober20202025

The 2019 accounts came in latest, 22 days after the end of the period.

Position in the sector

6.7%

Lower solvency than 88% of companies in human health. The sector median is 63.0%, over 21,385 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 2,154 companies had the same profile as PDEPIREUXNEURO has now. Each dot stands for 6 companies, two years later.

96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency under 10%
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 2,154 companies, not a prediction for PDEPIREUXNEURO. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 186 sharesdeed of 16-02-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0690602287
Amendment of the articles · Legal-form change · Resignations & appointments resigns as manager · reappointed as director · Discharge granted to · General meeting of 20-01-2024 · Gazette deed
Registered office moved from Overise to Huldenberg The registered office moved from Eeuw feestpton 2 bus 4, 3090 OVERISE to Leuvensebaan 194/4, 3040 HULDENBERG · General meeting of 01-09-2020 · Gazette deed
Registered office moved from Namur to Overijse The registered office moved from Rue de Coquelet 179/1, 5004 Namur (Bouge) to Eeuwfeestplein 2, 3090 Overijse · General meeting of 23-01-2019 · Gazette deed
All 16 events

Comparable companies

same main activity, similar in size and age
Company
PDEPIREUXNEURO Huldenberg €319,550 €110,474 6.7% -
Dr. L. Claes - gynaecologie - verloskunde Glabbeek €278,091 €112,416 52.0% -
Docteur Audrey Detrixhe Chaudfontaine €309,368 €111,726 12.0% -
Oogarts Dr. Eva Leloup Lede €284,125 €105,357 64.5% -
Nicolas PIQUARD - Gynécologie-Obstétrique Namur €279,490 €107,147 33.2% -
Docteur MCN - Hématologie Court-Saint-Etienne €301,253 €123,824 40.4% -
Dr. Sara Vansina, Dermatologie Leuven €315,966 €124,117 5.9% -

These companies have the same main activity as PDEPIREUXNEURO: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €278,000 and €316,000, founded between 2016 and 2018.

Official details

Source: KBO
Status
Active since 14-02-2018Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.273.203.5125004 Namur, since 14-02-2018
Financial year end
31 December
Peppol
Reachable since 19-05-2026
Company details

Annual accounts 2025

€319,550▲ 20.7%
Filing
Filed on 07-05-2026, 85 days before the end of the filing period
Financials

Insights on PDEPIREUXNEURO

PDEPIREUXNEURO files the micro format. That format states no turnover. The gross margin rose from €23,584 in 2018 to €110,474 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PDEPIREUXNEURO

What is the company number of PDEPIREUXNEURO?
The company number of PDEPIREUXNEURO is 0690.602.287. The VAT number is the same number with BE in front: BE 0690.602.287.
Where is PDEPIREUXNEURO based?
The registered office is at Leuvensebaan 194A, 3040 Huldenberg.Company details
What does PDEPIREUXNEURO do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of PDEPIREUXNEURO?
PDEPIREUXNEURO is a private limited company (BV).
When was PDEPIREUXNEURO founded?
PDEPIREUXNEURO was founded on 14-02-2018.
Is PDEPIREUXNEURO still active?
Yes, PDEPIREUXNEURO is an active enterprise in the KBO register.
What is the turnover of PDEPIREUXNEURO?
The turnover in financial year 2025 is about €210,000. This figure is estimated from the gross margin of €110,474 and 40 comparable companies (NACE 86220). It probably lies between €170,000 and €270,000.Financials
Is PDEPIREUXNEURO profitable?
In financial year 2025, PDEPIREUXNEURO made a profit of €76,062.
Where can I find the annual accounts of PDEPIREUXNEURO?
PDEPIREUXNEURO filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PDEPIREUXNEURO due?
PDEPIREUXNEURO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.